218 related articles for article (PubMed ID: 31572359)
1. Characteristic Pattern of IL-17RA, IL-17RB, and IL-17RC in Monocytes/Macrophages and Mast Cells From Patients With Bullous Pemphigoid.
Nesmond S; Muller C; Le Naour R; Viguier M; Bernard P; Antonicelli F; Le Jan S
Front Immunol; 2019; 10():2107. PubMed ID: 31572359
[TBL] [Abstract][Full Text] [Related]
2. Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes.
Riani M; Le Jan S; Plée J; Durlach A; Le Naour R; Haegeman G; Bernard P; Antonicelli F
J Allergy Clin Immunol; 2017 Mar; 139(3):863-872.e3. PubMed ID: 27637385
[TBL] [Abstract][Full Text] [Related]
3. Blister Fluid Induces MMP-9-Associated M2-Type Macrophages in Bullous Pemphigoid.
Riani M; Muller C; Bour C; Bernard P; Antonicelli F; Le Jan S
Front Immunol; 2019; 10():1858. PubMed ID: 31440247
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin.
Johansen C; Usher PA; Kjellerup RB; Lundsgaard D; Iversen L; Kragballe K
Br J Dermatol; 2009 Feb; 160(2):319-24. PubMed ID: 19016708
[TBL] [Abstract][Full Text] [Related]
5. High levels of interleukin-8, soluble CD4 and soluble CD8 in bullous pemphigoid blister fluid. The relationship between local cytokine production and lesional T-cell activities.
Sun CC; Wu J; Wong TT; Wang LF; Chuan MT
Br J Dermatol; 2000 Dec; 143(6):1235-40. PubMed ID: 11122027
[TBL] [Abstract][Full Text] [Related]
6. Macrophages, but not T and B lymphocytes, are critical for subepidermal blister formation in experimental bullous pemphigoid: macrophage-mediated neutrophil infiltration depends on mast cell activation.
Chen R; Fairley JA; Zhao ML; Giudice GJ; Zillikens D; Diaz LA; Liu Z
J Immunol; 2002 Oct; 169(7):3987-92. PubMed ID: 12244200
[TBL] [Abstract][Full Text] [Related]
7. NET Formation in Bullous Pemphigoid Patients With Relapse Is Modulated by IL-17 and IL-23 Interplay.
Giusti D; Bini E; Terryn C; Didier K; Le Jan S; Gatouillat G; Durlach A; Nesmond S; Muller C; Bernard P; Antonicelli F; Pham BN
Front Immunol; 2019; 10():701. PubMed ID: 31019514
[No Abstract] [Full Text] [Related]
8. IL-23/IL-17 Axis Activates IL-1β-Associated Inflammasome in Macrophages and Generates an Auto-Inflammatory Response in a Subgroup of Patients With Bullous Pemphigoid.
Le Jan S; Muller C; Plee J; Durlach A; Bernard P; Antonicelli F
Front Immunol; 2019; 10():1972. PubMed ID: 31507596
[TBL] [Abstract][Full Text] [Related]
9. Monocytes enhance neutrophil-induced blister formation in an ex vivo model of bullous pemphigoid.
de Graauw E; Sitaru C; Horn MP; Borradori L; Yousefi S; Simon D; Simon HU
Allergy; 2018 May; 73(5):1119-1130. PubMed ID: 29222810
[TBL] [Abstract][Full Text] [Related]
10. Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid.
Bhol KC; Rojas AI; Khan IU; Ahmed AR
Cytokine; 2000 Jul; 12(7):1076-83. PubMed ID: 10880254
[TBL] [Abstract][Full Text] [Related]
11. Distinct compartmentalization of immune cells and mediators characterizes bullous pemphigoid disease.
Margaroli C; Bradley B; Thompson C; Brown MR; Giacalone VD; Bhatt L; Stoff B; Ahuja S; Springman E; Tirouvanziam R; Feldman RJ
Exp Dermatol; 2020 Dec; 29(12):1191-1198. PubMed ID: 33047366
[TBL] [Abstract][Full Text] [Related]
12. Cutting Edge: IL-17B Uses IL-17RA and IL-17RB to Induce Type 2 Inflammation from Human Lymphocytes.
Ramirez-Carrozzi V; Ota N; Sambandam A; Wong K; Hackney J; Martinez-Martin N; Ouyang W; Pappu R
J Immunol; 2019 Apr; 202(7):1935-1941. PubMed ID: 30770417
[TBL] [Abstract][Full Text] [Related]
13. Elevated levels of interleukin-9 in the serum of bullous pemphigoid: possible association with the pathogenicity of bullous pemphigoid.
Koga H; Teye K; Sugawara A; Tsutsumi M; Ishii N; Nakama T
Front Immunol; 2023; 14():1135002. PubMed ID: 37398641
[TBL] [Abstract][Full Text] [Related]
14. Expression and location of IL-17A, E, F and their receptors in colorectal adenocarcinoma: Comparison with benign intestinal disease.
Liu Y; Sun X; Zhao X; An L; Wang Z; Jiang J; Shen W; Yang X; Sun Y
Pathol Res Pract; 2018 Apr; 214(4):482-491. PubMed ID: 29548809
[TBL] [Abstract][Full Text] [Related]
15. Distinctive expression pattern of interleukin-17 cytokine family members in colorectal cancer.
Al-Samadi A; Moossavi S; Salem A; Sotoudeh M; Tuovinen SM; Konttinen YT; Salo T; Bishehsari F
Tumour Biol; 2016 Feb; 37(2):1609-15. PubMed ID: 26304506
[TBL] [Abstract][Full Text] [Related]
16. Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with disease intensity.
Ameglio F; D'Auria L; Bonifati C; Ferraro C; Mastroianni A; Giacalone B
Br J Dermatol; 1998 Apr; 138(4):611-4. PubMed ID: 9640364
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of NLRP3 inflammasome components and interleukin-18 in patients with bullous pemphigoid.
Fang H; Shao S; Cao T; Lei J; Dang E; Zhang J; Wang G
J Dermatol Sci; 2016 Aug; 83(2):116-23. PubMed ID: 27174093
[TBL] [Abstract][Full Text] [Related]
18. Increased Activity and Apoptosis of Eosinophils in Blister Fluids, Skin and Peripheral Blood of Patients with Bullous Pemphigoid.
Engmann J; Rüdrich U; Behrens G; Papakonstantinou E; Gehring M; Kapp A; Raap U
Acta Derm Venereol; 2017 Apr; 97(4):464-471. PubMed ID: 27868136
[TBL] [Abstract][Full Text] [Related]
19. Innate immune cell-produced IL-17 sustains inflammation in bullous pemphigoid.
Le Jan S; Plée J; Vallerand D; Dupont A; Delanez E; Durlach A; Jackson PL; Edwin Blalock J; Bernard P; Antonicelli F
J Invest Dermatol; 2014 Dec; 134(12):2908-2917. PubMed ID: 24945093
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid.
Frezzolini A; Teofoli P; Cianchini G; Barduagni S; Ruffelli M; Ferranti G; Puddu P; De Pita O
Eur J Dermatol; 2002; 12(1):27-31. PubMed ID: 11809592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
